alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02-13-00038-CR

Ex parte Michael Owenga §

§

§

§

§

From Criminal District Court No. 2

of Tarrant County (C-2-009711-1200172-AP)

July 3, 2014

Per Curiam

(nfp)

JUDGMENT

This court has considered the record on appeal in this case and holds that 

there was no error in the trial court’s judgment. It is ordered that the judgment of 

the trial court is affirmed.

SECOND DISTRICT COURT OF APPEALS 

PER CURIAM
Editorial Note on Part 1204
Editorial Note: Nomenclature changes to part 1204 appear at 77 FR 4646, Jan. 31, 2012.

§ 1204.1 Why did FHFA issue this part? The Federal Housing Finance Agency (FHFA) issued this part to— ( a ) Implement the Privacy Act, a Federal law that helps protect private information about individuals that Federal agencies collect or maintain. You should read this part together with the Privacy Act, which provides additional information about records maintained on individuals;
( b ) Establish rules that apply to all FHFA and FHFA Office of Inspector General (FHFA-OIG) maintained systems of records retrievable by an individual's name or other personal identifier;
( c ) Describe procedures through which you may request access to records, request amendment or correction of those records, or request an accounting of disclosures of those records by FHFA or FHFA-OIG;
( d ) Inform you, that when it is appropriate to do so, FHFA or FHFA-OIG automatically processes a Privacy Act request for access to records under both the Privacy Act and FOIA, following the rules contained in this part and in FHFA's Freedom of Information Act regulation at part 1202 of this title so that you will receive the maximum amount of information available to you by law;
( e ) Notify you that this part does not entitle you to any service or to the disclosure of any record to which you are not entitled under the Privacy Act. It also does not, and may not be relied upon, to create any substantive or procedural right or benefit enforceable against FHFA or FHFA-OIG; and
( f ) Notify you that this part applies to both FHFA and FHFA-OIG.
IN THE SUPREME COURT OF THE STATE OF MONTANA

DA 21-0126

_________________

IN RE THE REINSTATEMENT OF

THE DRIVER'S LICENSE OF

CHARLEE BLAYLOCK,

 Petitioner and Appellant.

O R D E R

_________________

Pursuant to the Internal Operating Rules of this Court, this cause is classified for 

submission on briefs to a five-justice panel of this Court. 

The Clerk is directed to provide a copy hereof to all counsel of record and to the 

Honorable Brenda Gilbert, District Judge.

For the Court,

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

February 2 2022

02/02/2022

Case Number: DA 21-0126
§ 1222.22 Appraiser panel—annual size calculation. For purposes of determining whether, within a 12-month period, an AMC oversees an appraiser panel of more than 15 State-certified or State-licensed appraisers in a State or 25 or more State-certified or State-licensed appraisers in two or more States pursuant to § 1222.21(c)(1)(iii)— ( a ) An appraiser is deemed part of the AMC's appraiser panel as of the earliest date on which the AMC: ( 1 ) Accepts the appraiser for the AMC's consideration for future appraisal assignments in covered transactions or for secondary mortgage market participants in connection with covered transactions; or
( 2 ) Engages the appraiser to perform one or more appraisals on behalf of a creditor for a covered transaction or secondary mortgage market participant in connection with covered transactions.
( b ) An appraiser who is deemed part of the AMC's appraiser panel pursuant to paragraph (a) of this section is deemed to remain on the panel until the date on which the AMC: ( 1 ) Sends written notice to the appraiser removing the appraiser from the appraiser panel, with an explanation of its action; or
( 2 ) Receives written notice from the appraiser asking to be removed from the appraiser panel or notice of the death or incapacity of the appraiser.
( c ) If an appraiser is removed from an AMC's appraiser panel pursuant to paragraph (b) of this section, but the AMC subsequently accepts the appraiser for consideration for future assignments or engages the appraiser at any time during the twelve months after the AMC's removal, the removal will be deemed not to have occurred, and the appraiser will be deemed to have been part of the AMC's appraiser panel without interruption.
( d ) The period for purposes of counting appraisers on an AMC's appraiser panel may be the calendar year or a 12-month period established by law or rule of each State with which the AMC is required to register.
# CI2021262EN.01000101.xml

| 5.7.2021 | EN | Official Journal of the European Union | CI 262/1 |
| --- | --- | --- | --- |

5.7.2021

EN

Official Journal of the European Union

CI 262/1

---

Information communicated by Member States regarding closure of fisheries

(2021/C 262 I/01)

In accordance with Article 35(3) of Council Regulation (EC) No 1224/2009 of 20 November 2009 establishing a Union control system for ensuring compliance with the rules of the common fisheries policy (1), a decision has been taken to close the fishery as set down in the following table:

| Date and time of closure | 3.6.2021 |
| --- | --- |
| Duration | 3.6.2021 - 31.12.2021 |
| Member State | France |
| Stock or Group of stocks | ANF/8C3411 |
| Species | Anglerfish (Lophiidae) |
| Zone | 8c, 9 and 10; Union waters of CECAF 34.1.1 |
| Type(s) of fishing vessels | --- |
| Reference number | 08/TQ92 |

Date and time of closure

3.6.2021

Duration

3.6.2021 - 31.12.2021

Member State

France

Stock or Group of stocks

ANF/8C3411

Species

Anglerfish (Lophiidae)

Zone

8c, 9 and 10; Union waters of CECAF 34.1.1

Type(s) of fishing vessels

---

Reference number

08/TQ92

---

(1)  OJ L 343, 22.12.2009, p. 1.

---
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<RESTATED> 
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-26-1998
<PERIOD-START>                             DEC-28-1997
<PERIOD-END>                               MAR-28-1998
<CASH>                                          11,544
<SECURITIES>                                    35,068
<RECEIVABLES>                                   17,394
<ALLOWANCES>                                         0
<INVENTORY>                                     24,548
<CURRENT-ASSETS>                                97,844
<PP&E>                                          17,593
<DEPRECIATION>                                 (9,476)
<TOTAL-ASSETS>                                 106,153
<CURRENT-LIABILITIES>                           16,668
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           201
<OTHER-SE>                                      89,485
<TOTAL-LIABILITY-AND-EQUITY>                   106,153
<SALES>                                         28,348
<TOTAL-REVENUES>                                29,922
<CGS>                                           18,659
<TOTAL-COSTS>                                   31,708
<OTHER-EXPENSES>                                    76
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (295)<F1>
<INCOME-PRETAX>                                (3,141)
<INCOME-TAX>                                   (1,162)
<INCOME-CONTINUING>                            (1,979)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,979)
<EPS-PRIMARY>                                   (0.10)
<EPS-DILUTED>                                   (0.10)
<FN>
<F1>INTEREST INCOME
</FN>
        

</TABLE>
#### § 8.5 Authorization for deduction of premiums from compensation, retirement pay, or pension.

Deductions from benefits for the payment of premiums shall be effective on the month the authorization for such deduction is received by the Department of Veterans Affairs or on any successive month specified by the insured. Such deduction shall be applied to the premium due in the succeeding calendar month and shall continue monthly so long as the benefit payments are due and payable to the insured and the amount is sufficient to pay the premium or until such authorization is revoked by the veteran or otherwise terminated. When premium deductions are authorized by the insured, the premium will be treated as paid for purposes of preventing lapse of the insurance, so long as there is due and payable to the insured a benefit amount sufficient to provide the premium payment. If authorization was executed by the Director of a VA hospital or domiciliary or chief officer of a State hospital or other institution to make deductions from an institutional award, the authorization will cease and terminate at the termination of the institutional award and the insurance shall lapse unless another authorization for deduction from monthly benefit payments is executed by the insured. The insured will be notified by letter directed to the last address of record of the termination of the authorization to deduct premiums, but failure to give such notice shall not prevent lapse.

[61 FR 29291, June 10, 1996. Redesignated at 65 FR 7437, Feb. 15, 2000]
Petition Denied and Memorandum Opinion filed October 28 , 2021

.

In The 

## Fourteenth Court of Appeals

NO. 14

- 21

- 00336

- CV

ALICE ADRIANNE JARMAN , Appellant

V.
BELINDA DIANNE JARMAN BROWN COSBY AND CHERYL LYNN

JARMAN FOSTER , Appellee s

On Appeal from the Probate Court No

. 4

Harris County, Texas Trial Court Cause No. 441992

- 401

MEMORANDUM OPINION
Appellant Alice Adrianne Jarman petitions this court to allow a permissive interlocutory appeal of the trial court’s June 3, 2021 amended order denying appellant ’ s motion for summary judgment

. To be to a permissive appeal from an interlocutory order that would not
otherwise entitled be appealable, the requesting party must establish that (1) the order to be appealed involves a “controlling question of law as to which there is a2

substantial ground for difference of opinion” and (2) an immediate appeal from the order “may materially advan ce the ultimate termination of the litigation.” Tex. Civ. Prac. & Rem. Code Ann. § 51.014(d) ; see also Tex. R. App. P. 28.3(a) , (e)(4); Tex.
R. Civ. P. 168

. After reviewing the petition, the record, appellees’ response, and appellant ’s reply, we conclude that the petition does not meet the requirements for a permissive interlocutory appeal.
Accordingly, we deny the petition for permissive interlocutory appeal

.

PER CURIAM

Panel c onsists of Justices Wise
, Jewell , and Spain.
Exhibit 32  CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PUSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q for the period ended April 30, 2012 fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report fairly presents in all material respect the financial condition and results of operations of Vitro Diagnostics, Inc.   Date:  June 19, 2012 By: ____/s/James R. Musick______ Name:  James R. Musick Title: President, Chairman, Chief Executive Officer and Principal Financial Officer Vitro Diagnostics, Inc.
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2688 Placed on Calendar Senate (PCS)]

                                                       Calendar No. 315
110th CONGRESS
  1st Session
                                H. R. 2688

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 31, 2007

                                Received

                             August 1, 2007

                 Read twice and placed on the calendar

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
at 103 South Getty Street in Uvalde, Texas, as the ``Dolph Briscoe, Jr. 
                        Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DOLPH BRISCOE, JR. POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 103 South Getty Street in Uvalde, Texas, shall be known and 
designated as the ``Dolph Briscoe, Jr. Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Dolph 
Briscoe, Jr. Post Office Building''.

            Passed the House of Representatives July 30, 2007.

            Attest:

                                            LORRAINE C. MILLER,

                                                                 Clerk.
                                                       Calendar No. 315

110th CONGRESS

  1st Session

                               H. R. 2688

_______________________________________________________________________

                                 AN ACT

 To designate the facility of the United States Postal Service located 
at 103 South Getty Street in Uvalde, Texas, as the ``Dolph Briscoe, Jr. 
                        Post Office Building''.

_______________________________________________________________________

                             August 1, 2007

                 Read twice and placed on the calendar
```
[Federal Register Volume 74, Number 188 (Wednesday, September 30, 2009)]
[Notices]
[Page 50217]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-23615]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Allergy, Immunology, and Transplantation 
Research Committee; Allergy, Immunology & Transplantation Research 
Review Committee.
    Date: October 15, 2009.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Chicago, 151 Wacker Drive, Chicago, IL 
60601.
    Contact Person: Katrin Eichelberg, PhD, Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892, 301-496-0818, <a href="/cdn-cgi/l/email-protection#305b55595358555c52554257705e595159541e5e59581e575f46"><span class="__cf_email__" data-cfemail="7c1719151f1419101e190e1b3c12151d151852121514521b130a">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-23615 Filed 9-29-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
§ 1240.162 Mechanics of operational risk risk-weighted asset calculation. ( a ) If an Enterprise does not qualify to use or does not have qualifying operational risk mitigants, the Enterprise's dollar risk-based capital requirement for operational risk is its operational risk exposure minus eligible operational risk offsets (if any).
( b ) If an Enterprise qualifies to use operational risk mitigants and has qualifying operational risk mitigants, the Enterprise's dollar risk-based capital requirement for operational risk is the greater of: ( 1 ) The Enterprise's operational risk exposure adjusted for qualifying operational risk mitigants minus eligible operational risk offsets (if any); or
( 2 ) 0.8 multiplied by the difference between: ( i ) The Enterprise's operational risk exposure; and
( ii ) Eligible operational risk offsets (if any).
( c ) The Enterprise's risk-weighted asset amount for operational risk equals the greater of: ( 1 ) The Enterprise's dollar risk-based capital requirement for operational risk determined under paragraphs (a) or (b) multiplied by 12.5; and
( 2 ) The Enterprise's adjusted total assets multiplied by 0.0015 multiplied by 12.5.
( d ) After January 1, 2022, and until the compliance date for this section under § 1240.4, the Enterprise's risk weighted amount for operational risk will equal the Enterprise's adjusted total assets multiplied by 0.0015 multiplied by 12.5.
RYAM EX 10.2 Q1 2015


EXHIBIT 10.2


March __, 2015 
Paul Boynton
Chief Executive Officer
Rayonier Advanced Materials Inc.
1301 Riverplace Blvd.
Jacksonville, FL 32207
Dear Paul: 
Reference is made to the stock-settled retention award described in a letter to you dated May 28, 2014 (the “Original Agreement”), approved by the Rayonier Inc. Board of Directors as an incentive in connection with the spin-off and your efforts in your capacity as Chief Executive Officer of Rayonier Advanced Materials Inc. (“RYAM”) to enhancing RYAM shareholder value.  Terms not defined herein have the meaning set forth in the Original Agreement.    


The Board of Directors of RYAM has determined that it is in the best interest of RYAM to convert the stock-settled retention award into a cash award as provided in this letter agreement. As a result, the Original Agreement is hereby amended to provide that the $4 million retention award provided for thereunder will be payable, subject to satisfaction of the Employment Condition, solely in cash, and such amount, when paid, will be credited with interest at a fixed rate of 3.25%, which was based on the March 21, 2015, WSJ Prime Interest Rate.  The cash retention award will be paid to you within ten business days of satisfaction of the Employment Condition.  For the avoidance of doubt, you will have no right to Dividend Equivalents or related notional interest upon vesting.  


Except as expressly amended in this letter agreement, the Original Agreement will remain in full force and effect. The Original Agreement, as amended hereby, constitutes the entire agreement between the parties with respect to the cash retention award and no other agreement, oral or otherwise, shall be binding upon the parties unless it is in writing and signed by the party against whom enforcement is sought.  


* * * * 
Please indicate your understanding and agreement with the above by signing this document and returning it to my attention. 



	
			
	 
	 
	 








EXHIBIT 10.2


	
			
	 
	 

	By:
	 
	 

	Name:
	 
	Jay Posze

	Title:
	 
	SVP, Human Resources

	 
	 
	Rayonier Advanced Materials Inc.






	
	
	

ACCEPTED AND AGREED:

	 

	 

	Paul Boynton

	Date:
§ 1320.11 Consultation with financial market utility. Before providing a financial market utility notice of a proposed determination under § 1320.12, the Council shall provide the financial market utility with— ( a ) Written notice that the Council is considering whether to make a proposed determination with respect to the financial market utility under § 1320.13; and
( b ) An opportunity to submit written materials to the Council, within such time as the Council determines to be appropriate, concerning— ( 1 ) Whether the financial market utility is systemically important taking into consideration the factors set out in § 1320.10; and
( 2 ) Proposed changes by the financial market utility that could— ( i ) Reduce or increase the inherent systemic risk the financial market utility poses and the need for designation under § 1320.13; or
( ii ) Reduce or increase the appropriateness of rescission under § 1320.13.
( 3 ) The Council shall consider any written materials timely submitted by the financial market utility under this section before making a proposed determination under section 1320.13.
Exhibit 32
                    CERTIFICATION PURSUANT TO
                         18 U.S.C. 1350,
                     AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In  connection with the Quarterly Report of AEI Real Estate  Fund
XV Limited Partnership (the "Partnership") on Form 10-QSB for the
period  ended  March 31, 2004, as filed with the  Securities  and
Exchange  Commission  on  the  date hereof  (the  "Report"),  the
undersigned, Robert P. Johnson, President of AEI Fund  Management
86-A, Inc., the Managing General Partner of the Partnership,  and
Patrick  W. Keene, Chief Financial Officer of AEI Fund Management
86-A,  Inc., each certify, pursuant to 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

     1.   The  Report  fully  complies with the  requirements  of
          Section  13(a) or 15(d) of the Securities Exchange  Act
          of 1934; and

     2.   The   information  contained  in  the   Report   fairly
          presents,  in  all  material  respects,  the  financial
          condition and results of operations of the Partnership.


                          /s/ Robert P Johnson
                              Robert P. Johnson, President
                              AEI Fund Management 86-A, Inc.
                              Managing General Partner
                              May 11, 2004


                          /s/ Patrick W Keene
                              Patrick W. Keene, Chief Financial Officer
                              AEI Fund Management 86-A, Inc.
                              Managing General Partner
                              May 11, 2004